Computed from ACMR's own SEC filings (FY2025), benchmarked against ACLS and VECO. Every figure is deterministic — no estimates, no AI math — and in the full pack the subject's figures cite their exact SEC filing (tag, form and period), with every company identified by its CIK.
| Metric | ACMRFY2025 · 2025-12-31 | ACLSFY2025 · 2025-12-31 | VECOFY2025 · 2025-12-31 | Peer med. | Pctile |
|---|---|---|---|---|---|
| Revenue | $901.3M | $839.0M | $664.3M | $751.7M | 100th of 2 |
| Revenue growth (YoY) | 15.2% | -17.6% | -7.4% | -12.5% | 100th of 2 |
| Operating margin | 12.1% | 14.2% | 5.4% | 9.8% | 50th of 2 |
| Net margin | 10.4% | 14.3% | 5.3% | 9.8% | 50th of 2 |
| FCF margin | -7.4% | 12.8% | 8.0% | 10.4% | 0th of 2 |
| Capex % of revenue | 6.2% | 1.3% | 2.4% | 1.9% | 100th of 2 |
| Gross margin | — | — |
| SG&A % · R&D % · tax rate | — | — |
| Net debt/EBITDA · cash-conversion cycle · buybacks | — | — |
Each column is that company's own annual period — its fiscal year and period end are printed in the header. Fiscal calendars differ across companies, so each peer is shown on the annual period ending closest to ACMR's 2025-12-31, never a later filing than the subject's own year; a peer with no period within 400 days of it is not published here at all. Green/red = better/worse than the peer median where direction is unambiguous. Percentile = share of these peers at or below ACMR's value. The full pack adds up to 12 same-sector peers you choose, up to 13 extended metrics where disclosed, trends for every filed year (up to five), and a provenance table citing the subject's figures to their SEC tag, form and period and identifying every company by its CIK. A subscription covers as many packs as you need, on any covered company, generated on demand; 14-day refund if any figure misstates its cited filing. Informational benchmarking from public SEC data — not investment advice. — Sam, CompsDesk